Kojima K, Nakashima F, Boku A, Muroishi Y, Nakanishi I, Oda Y
Molecular and Cellular Pathology, Graduate School of Medical Science, Kanazawa University, Takaramachi 13-1, Kanazawa, Ishikawa 920-8640, Japan.
Histol Histopathol. 2002 Oct;17(4):1005-16. doi: 10.14670/HH-17.1005.
Involvement of granulocyte colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) in non-lymphohematopoietic malignant tumors accompanied by leukocytosis was clinicopathologically investigated. Among 1,778 autopsy cases in the last 20 years, 485 lesions of 439 cases with non-lymphohematopoietic malignant tumors accompanied by leukocytosis with a white blood cell count of 10,000/mm3 or greater during the course were immunohistologically examined for G-CSF and GM-CSF. Three (0.7%) and two cases (0.5%) were G-CSF- and GM-CSF-positive, respectively. GM-CSF mRNA was confirmed by using non-fixed cryopreserved tumor tissues in one case positive for GM-CSF. G-CSF-positive cases were large cell carcinoma of the lung, adenocarcinoma of the colon, and adenocarcinoma of the stomach, and GM-CSF-positive cases were spindle cell carcinoma of the lung and malignant thymoma. In the case with stomach carcinoma, the primary lesion showing moderately differentiated adenocarcinoma was negative, but the lung metastatic lesion showing less differentiated adenocarcinoma was G-CSF-positive. The survival period was six months or less in four out of five positive cases. The highest white blood cell count in five CSF-positive cases was markedly elevated: 29,400-103,500/mm3 (mean: 59,700/mm3). In four cases, excluding one case which may have been markedly affected by chemotherapy, the bone marrow showed hyperplasia, and the number of the granulocyte series cells significantly increased. There were three cases (0.7%) negative for both G-CSF and GM-CSF, although they showed marked leukocytosis (60,000/mm3 or higher) which were higher than the mean count of CSF-positive cases and was not observed in autopsy cases with non-tumorous diseases. Other stimulating factors may be involved in the development of leukocytosis in such cases.
对伴有白细胞增多的非淋巴造血系统恶性肿瘤中粒细胞集落刺激因子(G-CSF)和粒细胞-巨噬细胞集落刺激因子(GM-CSF)的参与情况进行了临床病理研究。在过去20年的1778例尸检病例中,对439例伴有白细胞增多(病程中白细胞计数为10000/mm³或更高)的非淋巴造血系统恶性肿瘤的485个病灶进行了G-CSF和GM-CSF的免疫组织化学检查。G-CSF阳性的有3例(0.7%),GM-CSF阳性的有2例(0.5%)。在1例GM-CSF阳性病例中,使用未固定的冷冻保存肿瘤组织证实了GM-CSF mRNA。G-CSF阳性病例为肺大细胞癌、结肠腺癌和胃腺癌,GM-CSF阳性病例为肺梭形细胞癌和恶性胸腺瘤。在胃癌病例中,显示中分化腺癌的原发灶为阴性,但显示低分化腺癌的肺转移灶为G-CSF阳性。5例阳性病例中有4例生存期为6个月或更短。5例CSF阳性病例中的最高白细胞计数显著升高:29400 - 103500/mm³(平均:59700/mm³)。在4例中,排除1例可能受化疗显著影响的病例后,骨髓显示增生,粒细胞系列细胞数量显著增加。有3例(0.7%)G-CSF和GM-CSF均为阴性,尽管它们显示出明显的白细胞增多(60000/mm³或更高),高于CSF阳性病例的平均计数,且在非肿瘤性疾病的尸检病例中未观察到。其他刺激因子可能参与了此类病例中白细胞增多的发生。